PTMA is involved in controlling cell growth, differentiation, and immune responses. It binds to the PTEN promoter to boost its expression and works with TRIM21 to regulate Nrf2 signaling, acting as a tumor suppressor, especially in bladder cancer. Additionally, as an important immune mediator, PTMA might be targeted for treating or diagnosing immune-related conditions like cancer, inflammation, and sepsis.